title: Intrabodies as neuroprotective therapeutics.
abstract: The process of misfolding of proteins that can trigger a pathogenic cascade leading to neurodegenerative diseases largely originates intracellularly. It is possible to harness the specificity and affinity of antibodies to counteract either protein misfolding itself, or the aberrant interactions and excess stressors immediately downstream of the primary insult. This review covers the emerging field of engineering intracellular antibody fragments, intrabodies and nanobodies, in neurodegeneration. Huntington's disease has provided the clearest proof of concept for this approach. The model systems and readouts for this disorder power the studies, and the potential to intervene therapeutically at early stages in known carriers with projected ages of onset increases the chances of meaningful clinical trials. Both single-chain Fv and single-domain nanobodies have been identified against specific targets; data have allowed feedback for rational design of bifunctional constructs, as well as target validation. Intrabodies that can modulate the primary accumulating protein in Parkinson's disease, alpha-synuclein, are also reviewed, covering a range of domains and conformers. Recombinant antibody technology has become a major player in the therapeutic pipeline for cancer, infectious diseases, and autoimmunity. There is also tremendous potential for applying this powerful biotechnology to neurological diseases.
authors: New York State Dept of Health, Wadsworth Center, Albany, NY 12208, USA. messer@wadsworth.org
authors: Anne
authors: A
authors: Messer
authors: Shubhada N
authors: SN
authors: Joshi
mesh_terms: D000818:Animals; D006801:Humans; D006816:Huntington Disease / Q000276:immunology / Q000628:therapy*; D007128:Immunoglobulin Fragments / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D015202:Protein Engineering; D017510:Protein Folding / Q000187:drug effects; D057165:Proteostasis Deficiencies / Q000276:immunology / Q000628:therapy*
chemical_list: D007128:Immunoglobulin Fragments; D018696:Neuroprotective Agents
references: Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):260-5
references: 21173221
references: JAMA. 2006 Aug 9;296(6):661-70
references: 16896109
references: J Biol Chem. 2001 Jan 26;276(4):2380-6
references: 11060312
references: Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17616-21
references: 15598740
references: J Mol Biol. 2011 Nov 4;413(4):879-87
references: 21945530
references: Mol Neurodegener. 2009 Feb 04;4:9
references: 19193223
references: Hum Mol Genet. 2009 May 15;18(10):1849-59
references: 19258344
references: Hum Gene Ther. 1998 Jul 20;9(11):1627-42
references: 9694161
references: Appl Microbiol Biotechnol. 2007 Nov;77(1):13-22
references: 17704915
references: Neurobiol Dis. 2011 Jan;41(1):43-50
references: 20736066
references: J Neurosci. 2004 Jan 7;24(1):269-81
references: 14715959
references: Brain Res. 1999 Jul 17;835(1):74-9
references: 10448198
references: Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1002-7
references: 11792860
references: J Neurosci. 2009 Oct 28;29(43):13589-602
references: 19864571
references: J Mol Biol. 2012 Aug 24;421(4-5):466-90
references: 22306404
references: Neurobiol Dis. 2005 Jun-Jul;19(1-2):47-56
references: 15837560
references: Hum Mol Genet. 2012 Feb 1;21(3):495-510
references: 22045698
references: Hum Mol Genet. 2003 Dec 15;12(24):3359-67
references: 14570710
references: Lancet. 2011 Feb 19;377(9766):641-9
references: 21292315
references: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4764-9
references: 11296304
references: Nat Biotechnol. 2010 Mar;28(3):256-63
references: 20190739
references: Autophagy. 2012 Mar;8(3):431-2
references: 22361581
references: J Neuropathol Exp Neurol. 2010 Oct;69(10):1078-85
references: 20838238
references: BMC Evol Biol. 2008 Aug 11;8:231
references: 18694497
references: Handb Exp Pharmacol. 2008;(181):343-73
references: 18071953
references: Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):141-5
references: 14969746
references: PLoS One. 2011;6(12):e29199
references: 22216210
references: Brain Res Bull. 2001 Oct-Nov 1;56(3-4):319-29
references: 11719267
references: J Mol Biol. 2010 Sep 17;402(2):326-43
references: 20620148
references: EMBO J. 2007 Jul 11;26(13):3250-9
references: 17568777
references: Sci Transl Med. 2011 May 25;3(84):84ra44
references: 21613623
references: J Mol Biol. 2004 Jul 9;340(3):525-42
references: 15210352
references: Annu Rev Pathol. 2011;6:193-222
references: 21034221
references: Hum Mol Genet. 2007 Jan 1;16(1):61-77
references: 17135277
references: Neuron. 2012 Jun 21;74(6):964-6
references: 22726826
references: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17204-9
references: 17940007
references: Hum Mol Genet. 2011 Apr 15;20(R1):R28-41
references: 21429918
references: Curr Opin Mol Ther. 2007 Aug;9(4):327-35
references: 17694445
references: Sci Transl Med. 2011 May 25;3(84):84ra43
references: 21613622
references: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19232-7
references: 18042730
references: Cell. 1996 Nov 1;87(3):493-506
references: 8898202
references: Science. 2004 Apr 2;304(5667):100-4
references: 15064418
references: Mol Neurodegener. 2011 Jan 18;6(1):6
references: 21244648
references: Prog Neurobiol. 2012 May;97(2):190-204
references: 22120646
references: J Mol Biol. 2004 Sep 17;342(3):901-12
references: 15342245
references: Hum Mol Genet. 2003 Jul 1;12(13):1555-67
references: 12812983
references: Ann Neurol. 2011 Jun;69(6):940-53
references: 21472771
references: Int J Biochem Cell Biol. 2009 Mar;41(3):554-60
references: 18687409
references: Neuron. 2012 Jun 21;74(6):1031-44
references: 22726834
references: Mol Neurobiol. 2013 Apr;47(2):509-24
references: 22923347
references: J Mol Biol. 2008 Mar 14;377(1):136-47
references: 18237741
references: Hum Gene Ther. 2011 May;22(5):595-604
references: 21410419
references: Trends Biochem Sci. 1996 Jul;21(7):267-71
references: 8755249
references: Neurobiol Dis. 2010 Oct;40(1):130-4
references: 20399860
references: Neuron. 2010 Jan 14;65(1):66-79
references: 20152114
references: Expert Opin Biol Ther. 2007 May;7(5):677-89
references: 17477805
references: J Neurosci. 2008 Sep 3;28(36):9013-20
references: 18768695
references: MAbs. 2012 Nov-Dec;4(6):686-93
references: 22929188
references: Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):178-83
references: 19026455
references: J Cell Biol. 2008 Jun 2;181(5):803-16
references: 18504298
references: Stroke. 2010 Mar;41(3):538-43
references: 20075343
references: Exp Neurol. 2001 Feb;167(2):215-26
references: 11161610
references: J Biol Chem. 2009 Apr 24;284(17):11048-58
references: 19141614
references: Mol Cell Biol. 1988 Jun;8(6):2638-46
references: 3136320
references: Hum Mol Genet. 2002 Oct 15;11(22):2689-700
references: 12374759
references: Protein Eng Des Sel. 2010 Jun;23(6):489-98
references: 20378699
references: J Neurosci. 2007 Mar 21;27(12):3338-46
references: 17376994
references: J Mol Biol. 2007 May 11;368(4):1132-44
references: 17391701
references: Trends Mol Med. 2008 Sep;14(9):373-80
references: 18693139
references: Hum Mol Genet. 2010 Jun 1;19(11):2144-53
references: 20190273
references: Hum Mol Genet. 2002 May 1;11(9):1107-17
references: 11978769
references: Biochim Biophys Acta. 2009 Jul;1792(7):634-42
references: 18834937
references: Brain Res. 2012 Jun 26;1462:100-11
references: 22405728
references: J Mol Biol. 2013 Jul 24;425(14):2397-411
references: 23557833
references: J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77
references: 2932539
references: J Neurosci. 2008 Jun 11;28(24):6182-95
references: 18550760
references: Mol Ther. 2013 Jan;21(1):158-66
references: 22929660
references: PLoS One. 2009 May 28;4(5):e5727
references: 19492089
references: FEBS J. 2008 Sep;275(17):4263-70
references: 18637946
references: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9879-84
references: 20457918
references: Neuropsychiatr Dis Treat. 2008 Oct;4(5):835-45
references: 19183776
references: FEBS Lett. 2012 Jan 2;586(1):7-12
references: 22119730
references: Expert Opin Biol Ther. 2009 Sep;9(9):1189-97
references: 19653865
references: Cell. 1993 Mar 26;72(6):971-83
references: 8458085
references: Neuron. 2011 Feb 10;69(3):423-35
references: 21315254
references: PLoS One. 2009;4(5):e5515
references: 19436756
references: J Biol Chem. 2012 Mar 23;287(13):9982-9989
references: 22187438
references: Mol Ther. 2003 May;7(5 Pt 1):572-9
references: 12718899
references: Neurosci Lett. 2009 Jul 31;459(1):16-8
references: 19394405
references: BioDrugs. 2006;20(6):327-33
references: 17176119
references: Nat Genet. 2000 Nov;26(3):300-6
references: 11062468
references: Biomol NMR Assign. 2009 Dec;3(2):231-3
references: 19763886
references: J Comp Neurol. 2003 Oct 6;465(1):11-26
references: 12926013
references: Adv Protein Chem. 1996;49:329-450
references: 8908302
references: Neuron. 2009 Dec 24;64(6):828-40
references: 20064390
references: Mol Ther. 2004 Dec;10(6):1023-31
references: 15564134
references: J Mol Biol. 2011 Dec 2;414(3):337-55
references: 21968397
references: PLoS One. 2011 Jan 31;6(1):e16676
references: 21304966
references: J Biol Chem. 2009 Oct 23;284(43):29427-36
references: 19710014
references: Neurobiol Dis. 2012 Nov;48(2):243-54
references: 22222669
references: Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11563-8
references: 16061794
references: Nat Rev Drug Discov. 2011 May;10(5):377-93
references: 21532567
references: FASEB J. 2008 Jun;22(6):2003-11
references: 18199697
references: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503
references: 14993615
references: Cell Oncol. 2008;30(5):397-409
references: 18791271